Scarica l'app Stockscreener
1.96
1.55%
0.03
Dopo l'orario di chiusura:
1.95
-0.01
-0.51%
Vor Biopharma Inc Borsa (VOR) Ultime notizie
What is Vor Biopharma Inc. s 5 year growth outlookInsider Buying & Fast Exit Strategy with Risk Control - خودرو بانک
How cyclical is Vor Biopharma Inc.’s revenue streamJuly 2025 Trends & Accurate Entry and Exit Point Alerts - خودرو بانک
Measuring Vor Biopharma Inc.’s beta against major indicesStop Loss & Momentum Based Trading Signals - Newser
What’s next for Vor Biopharma Inc. stock priceQuarterly Earnings Summary & AI Powered Buy and Sell Recommendations - Newser
Sector ETF performance correlation with Vor Biopharma Inc.Earnings Summary Report & Long-Term Growth Plans - Newser
Can Vor Biopharma Inc. lead its sector in growthPortfolio Value Report & Weekly Breakout Opportunity Watchlist - خودرو بانک
Vor Biopharma shares rise 2.59% premarket after Connect Biopharma's Nasdaq listing. - AInvest
Is Vor Biopharma Inc. gaining market shareSwing Trade & Fast Gaining Stock Strategy Reports - خودرو بانک
Does Vor Biopharma Inc. fit your quant trading modelWeekly Trade Review & Capital Efficient Trading Techniques - Newser
Quantitative breakdown of Vor Biopharma Inc. recent moveOptions Play & High Win Rate Trade Tips - Newser
Is Vor Biopharma Inc. stock overvalued or fairly priced2025 Major Catalysts & Weekly High Return Stock Opportunities - خودرو بانک
Custom strategy builders for tracking Vor Biopharma Inc.2025 Big Picture & Verified Entry Point Signals - Newser
What data driven models say about Vor Biopharma Inc.’s futureShare Buyback & Stock Portfolio Risk Management - Newser
Real time social sentiment graph for Vor Biopharma Inc.July 2025 Catalysts & High Accuracy Swing Trade Signals - Newser
Price momentum metrics for Vor Biopharma Inc. explained2025 Market Sentiment & Consistent Growth Equity Picks - Newser
Is Vor Biopharma Inc. stock a good pick for beginnersJuly 2025 Opening Moves & High Accuracy Buy Signal Tips - خودرو بانک
Vor Biopharma Inc. stock trend outlook and recovery pathMarket Weekly Review & Long-Term Safe Investment Plans - Newser
Using data filters to optimize entry into Vor Biopharma Inc.July 2025 Drop Watch & Verified Technical Trade Signals - Newser
Applying chart zones and confluence areas to Vor Biopharma Inc.Bond Market & Consistent Profit Trade Alerts - Newser
Building trade automation scripts for Vor Biopharma Inc.Portfolio Return Summary & Expert-Curated Trade Recommendations - Newser
Can Vor Biopharma Inc. grow without external fundingJuly 2025 Institutional & Low Risk High Reward Trade Ideas - خودرو بانک
Using flow based indicators on Vor Biopharma Inc.Dividend Hike & Safe Capital Growth Stock Tips - Newser
Trend analysis for Vor Biopharma Inc. this weekEarnings Miss & Long-Term Growth Stock Strategies - Newser
How to integrate Vor Biopharma Inc. into portfolio analysis toolsJuly 2025 Technicals & Verified Momentum Stock Watchlist - Newser
Multi factor analysis applied to Vor Biopharma Inc.July 2025 Earnings & Weekly Top Gainers Trade List - Newser
Does Vor Biopharma Inc. show high probability of reboundJuly 2025 Decliners & Weekly High Potential Stock Alerts - Newser
Risk vs reward if holding onto Vor Biopharma Inc.July 2025 Reactions & Verified Swing Trading Watchlist - Newser
What is Vor Biopharma Inc.’s book value per share2025 Big Picture & Technical Pattern Based Buy Signals - خودرو بانک
Vor Biopharma Focuses on Telitacicept Development Strategy - MSN
Can Vor Biopharma Inc. recover in the next quarterIPO Watch & Expert Curated Trade Ideas - Newser
Harvard Law Graduate Adi Osovsky Joins Clinical-Stage Biotech Vor Bio as General Counsel After iTeos Success - Stock Titan
1.40%
Apri su Yahoo
|
Apri su Google
|
Aperto in Finviz
|
Apri in MarketWatch
|
Aperto a EDGAR
|
Aperto su Reuters
Capitalizzazione:
|
Volume (24 ore):